EUVIMEDEUVIMED entdecken
Open Access

Extracellular Vesicle-Derived Cord Blood Plasma and Photobiomodulation Therapy Down-Regulated Caspase 3, LC3 and Beclin 1 Markers in the PCOS Oocyte: An In Vitro Study

Samira Sahraeian iD, Hojjat Allah Abbaszadeh iD, Robabeh Taheripanah, Mohammad Amin Edalatmanesh

Journal of Lasers in Medical Sciences · 29.07.2023 · 14 · e23

DOI: 10.34172/jlms.2023.23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Lasers in Medical Sciences, online erschienen am 29.07.2023. Verfasst von Samira Sahraeian und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, College of Sciences, Shiraz Branch, Islamic Azad University, Shiraz, Iran. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Polycystic ovary syndrome (PCOS) is the communal endocrine illness in women and the most common cause of infertility due to lack of ovulation. The exact cause of PCOS is still unknown. Affected women may have difficulty getting pregnant due to ovulation problems. Various methods have not been effective in the treatment of PCOS due to the positive role of photobiomodulation therapy (PBMT) and extracellular vesicles (ECV) obtained from cord blood plasma in the treatment of various diseases. The aim of this study was to study the role of ECV and PBMT in maturation and improvement of infertility in women with PCOS.

Methods

In this research, a number of oocytes were obtained after ovarian stimulation from women who had been referred to the hospital for infertility treatment after obtaining personal consent, and they were divided into three groups: control, ECV and PBMT. Subsequently, in vitro maturation (IVM) was assessed, then some oocytes were cultured with a routine medium and others were treated with ECV and PBMT. Real-time PCR was used to evaluate BCL-2, BAX, caspase-3, and autophagy gene (ATG5, LC3, Beclin 1). Oocyte glutathione (GSH), oxidised gluathione (GSSG), and reactive oxygen species (ROS) were measured.

Results

The metaphase II (MII) oocyte ratio formation significantly increased in the ECV and PBMT groups (P

Schlagwörter

Stichwörter der Autor:innen

Caspase 3Cord blood plasmaExtracellular vesiclePolycystic ovary syndrome

Autor:innen und Institutionen

  • Department of Biology, College of Sciences, Shiraz Branch, Islamic Azad University, Shiraz, Iran.
  • Laser Applications in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Hearing Disorders research center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Obstetrics and Gynecology, School of medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Samira Sahraeian, Hojjat Allah Abbaszadeh

Zitieren

APA

Sahraeian, S., Abbaszadeh, H. A., Taheripanah, R., & Edalatmanesh, M. A. (2023). Extracellular Vesicle-Derived Cord Blood Plasma and Photobiomodulation Therapy Down-Regulated Caspase 3, LC3 and Beclin 1 Markers in the PCOS Oocyte: An In Vitro Study. Journal of Lasers in Medical Sciences, 14, e23. https://doi.org/10.34172/jlms.2023.23

Vancouver

Sahraeian S, Abbaszadeh HA, Taheripanah R, Edalatmanesh MA. Extracellular Vesicle-Derived Cord Blood Plasma and Photobiomodulation Therapy Down-Regulated Caspase 3, LC3 and Beclin 1 Markers in the PCOS Oocyte: An In Vitro Study. Journal of Lasers in Medical Sciences. 2023;14:e23. doi:10.34172/jlms.2023.23

BibTeX
@article{Sahraeian2023,
  author = {Sahraeian, Samira and Abbaszadeh, Hojjat Allah and Taheripanah, Robabeh and Edalatmanesh, Mohammad Amin},
  title = {Extracellular Vesicle-Derived Cord Blood Plasma and Photobiomodulation Therapy Down-Regulated Caspase 3, LC3 and Beclin 1 Markers in the PCOS Oocyte: An In Vitro Study},
  journal = {Journal of Lasers in Medical Sciences},
  year = {2023},
  volume = {14},
  pages = {e23},
  doi = {10.34172/jlms.2023.23}
}
Kostenlos starten →